GA NCORP

Treatment Sites

Harbin Clinic Cancer Center

Physical Address:  
255 West 5th Street
Rome, Georgia 30165

Harbin Clinic Radiation Oncology is accredited by the American College of Radiology. Harbin Clinic Medical Oncology is formerly a member of the Atlanta Regional Community Clinical Oncology Program, a program initiated by the National Cancer Institute to provide community hospitals access to a wide range of research studies.Additionally, Harbin Clinic is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. The Harbin Clinic is also a recipient of the Georgia Cancer Coalition Distinguished Cancer Scholars Award, which supports leaders who are engaged in the most promising areas of cancer research. Located in Rome, GA, Harbin Clinic has five physicians who specialize in medical and radiation oncology. The Clinic provides the following medical oncology services: cancer treatment, chemotherapy, and treatment of hematologic conditions. Harbin Clinic Radiation Oncology offers Northwest Georgia cancer patients cutting edge cancer treatment technology including state-of-the-art linear accelerators for Radiation Therapy delivery, access to advanced diagnostic radiologic imaging modalities such as CT, PET/CT and MRI. They also have intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Brachytherapy (Internal Radiotherapy), prostate seed implants for localized prostate cancer, Mammosite for early stages of breast cancer, and integrative oncology which combines evidence based complementary and alternative medicine with conventional medical therapies to create individualized plans to treat the whole person.

Treatment Sites


Primary Location

255 West Fifth Street
Rome, GA 30165
706-528-9110 (p)
706-528-9111 (f)
www.harbinclinic.com

driving directions

Clinical Trials

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Cancer Type: Breast Cancer

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer
Study Coordinator: Terri Brannon - 706-528-9094


DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Cancer Type: Appendix Cancer, Bone and Soft Tissue (including Sarcoma), Brain Cancer , Colon/Rectal Cancer, Unknown Primary

EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Eye Cancer, Lymphoma, Multiple Primaries, Non-Hodgkin Lymphoma, Solid Tumor, Unknown Primary
Study Coordinator: Terri Brannon - 706-528-9094